| __timestamp | BioCryst Pharmaceuticals, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 45967000 |
| Thursday, January 1, 2015 | 72758000 | 114737000 |
| Friday, January 1, 2016 | 61008000 | 183204000 |
| Sunday, January 1, 2017 | 66962000 | 231644000 |
| Monday, January 1, 2018 | 84888000 | 293998000 |
| Tuesday, January 1, 2019 | 107068000 | 357355000 |
| Wednesday, January 1, 2020 | 122964000 | 412084000 |
| Friday, January 1, 2021 | 208808000 | 497153000 |
| Saturday, January 1, 2022 | 253297000 | 705789000 |
| Sunday, January 1, 2023 | 216566000 | 648449000 |
Cracking the code
In the ever-evolving world of pharmaceuticals, innovation is the key to staying ahead. Over the past decade, Ultragenyx Pharmaceutical Inc. and BioCryst Pharmaceuticals, Inc. have demonstrated their commitment to research and development (R&D) with significant investments. From 2014 to 2023, Ultragenyx consistently outpaced BioCryst in R&D spending, peaking in 2022 with a staggering 605% increase from their 2014 expenditure. BioCryst, while more conservative, still showed a robust 318% growth over the same period. This trend highlights Ultragenyx's aggressive strategy in pioneering new treatments, while BioCryst maintains a steady, albeit slower, pace of innovation. As the pharmaceutical landscape continues to shift, these companies' R&D investments will likely play a crucial role in their future success and the development of groundbreaking therapies.
Research and Development Expenses Breakdown: Novartis AG vs Ultragenyx Pharmaceutical Inc.
R&D Insights: How Regeneron Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Intra-Cellular Therapies, Inc. vs Ultragenyx Pharmaceutical Inc.
R&D Insights: How Dr. Reddy's Laboratories Limited and BioCryst Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Ascendis Pharma A/S and Ultragenyx Pharmaceutical Inc. Allocate Funds
Analyzing R&D Budgets: Alkermes plc vs Ultragenyx Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alkermes plc and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and PTC Therapeutics, Inc.
Ultragenyx Pharmaceutical Inc. or ImmunityBio, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Ultragenyx Pharmaceutical Inc. and Travere Therapeutics, Inc.
R&D Spending Showdown: Vericel Corporation vs BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and BioCryst Pharmaceuticals, Inc.